Amoxi-Tabs C®-250
Broad-spectrum antibiotic with bacterial resistance inhibitor
Tablet Oral
Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.
For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.
1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.
Box x 10 tablets ,
Registro SAGARPA: México Registro SAGARPA Q-0616-030
Petmedica® is a division of Agrovet Market S.A.
Insert
Shared
Whatsapp
This content is an informational reference and should not be considered as
recommendation of use.
